NDC 50090-7406-01 - Glimepiride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7406
- Requested NDC
- 50090-7406-01
- Package NDCs from labels
- 50090-7406-0, 50090-7406-1, 50090-7406-2, 50090-7406-3, 50090-7406-4, 50090-7406-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-10-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glimepiride - A-S Medication Solutions | A-S Medication Solutions | 2024-10-25 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7406-0 | Glimepiride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-7406-1 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 50090-7406-2 | Glimepiride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 50090-7406-3 | Glimepiride | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 50090-7406-4 | Glimepiride | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7406 | GLIMEPIRIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 5 package rows | 20241027_79ee7533-f75d-4c49-b396-b339654f5c44.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7406-0 | EA - Each | 50090-7406 | 2f61a8d8-6261-4b86-a0d5-e780a2e1ac7a | 1 | 2024-12-10 |
| 50090-7406-1 | EA - Each | 50090-7406 | 8c17d3a2-58e2-4521-8f73-9c0079f45c0f | 1 | 2024-12-10 |
| 50090-7406-2 | EA - Each | 50090-7406 | e168ba01-bc43-4728-9fb2-01eabb2c2a5e | 1 | 2024-12-10 |
| 50090-7406-3 | EA - Each | 50090-7406 | ef70b145-eb95-48a1-8253-5b45ec9f8828 | 1 | 2024-12-10 |
| 50090-7406-4 | EA - Each | 50090-7406 | f50e9cc8-16af-4ef9-8432-39cda6bcaa4f | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 68cb4fcd-5bc3-4f53-9085-86df6a4246d6 | 2022-04-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Solco Healthcare U.S., LLC | 86acdd9e-8637-43e4-8bf7-b3a123b871b8 | 2021-08-13 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | ebb9f080-b11d-5d18-36f0-627107e7fbcd | 2020-08-27 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | NCS HealthCare of KY, Inc dba Vangard Labs | 669a67c2-2f97-4b7e-8bba-83a015e0fa94 | 2020-04-30 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Aphena Pharma Solutions - Tennessee, LLC | 00b9e312-921e-41e6-ad27-0a6ce87f8298 | 2019-02-13 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Dr. Reddy's Laboratories Limited | 07ad4366-4b21-f633-49f3-c2b35f88168d | 2019-01-16 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.